gracecastuc112_lung_dr. goldberg on which patients for markers molecular testing
Published 11 years ago • 22 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:35
gracecastuc 122 lung_dr. goldberg on which patients to seek molecular testing
-
2:35
gracecastuc-028_lung_dr. goldberg - pros & cons of molecular testing with delays & rebiopsy
-
3:32
gracecastuc100_lung_drs. camidge and langer on which patients send molecular marker testing
-
1:23
gracecastuc-067_lung_dr. goldberg on utility of molecular marker results in the adjuvant setting
-
1:10
gracecastuc-070_lung_dr. reckamp on "which patients do you test for molecular marker, and for what?"
-
1:59:57
grace - global resource for advancing cancer education live stream
-
9:50
an overview of kras nsclc and diagnostic testing - lcvl 2024
-
4:51
targeted therapy side effects - lcvl 2024
-
28:10
biomarkers of cancer
-
19:57
gracecast-015_cancer-101_david djang interview on pet scans
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
2:17
gracecastuc085_lung_dr. goldberg sampling methods on molecular testing
-
3:41
testing methods to discover egfr exon-20 disease - lung cancer video library
-
6:11
gracecastuc-012_lung_the more you seek, the more you find
-
13:04
gracecast-041_lung-cancer_screening, workup & follow-up
-
0:35
does radiation increase toxicity for patients on tt? - #youtubeshorts #shorts
-
1:17
gracecastuc104_lung_dr. goldberg on egfr mutation after starting chemo
-
17:28
gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
-
2:11
gracecastuc-039_lung_how i use molecular marker information in earlier stage nsclc patients
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
9:36
gracecast-021_lung-cancer_stage iiia management options